![]() 2-Deoxy-2-fluoro-D-glucose structure
|
Common Name | 2-Deoxy-2-fluoro-D-glucose | ||
---|---|---|---|---|
CAS Number | 29702-43-0 | Molecular Weight | 182.147 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 478.4±45.0 °C at 760 mmHg | |
Molecular Formula | C6H11FO5 | Melting Point | 170ºC | |
MSDS | Chinese USA | Flash Point | 243.1±28.7 °C | |
Symbol |
![]() GHS07 |
Signal Word | Warning |
Use of 2-Deoxy-2-fluoro-D-glucose2-Deoxy-2-fluoro-D-glucose is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | 2-Deoxy-2-fluoro-D-glucose |
---|---|
Synonym | More Synonyms |
Description | 2-Deoxy-2-fluoro-D-glucose is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 478.4±45.0 °C at 760 mmHg |
Melting Point | 170ºC |
Molecular Formula | C6H11FO5 |
Molecular Weight | 182.147 |
Flash Point | 243.1±28.7 °C |
Exact Mass | 182.059052 |
PSA | 97.99000 |
LogP | -2.37 |
Vapour Pressure | 0.0±2.7 mmHg at 25°C |
Index of Refraction | 1.505 |
Storage condition | 2-8°C |
Symbol |
![]() GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi: Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | 26-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
HS Code | 2932999099 |
HS Code | 2932999099 |
---|---|
Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Lancet 383(9918) , 705-13, (2014) The use of non-invasive imaging to identify ruptured or high-risk coronary atherosclerotic plaques would represent a major clinical advance for prevention and treatment of coronary artery disease. We ... |
|
11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT.
J. Nucl. Med. 55(5) , 749-52, (2014) We prospectively compared (11)C-acetate with (18)F-FDG in a PET/CT evaluation of multiple myeloma (MM), specifically on diagnostic accuracy, identification of high-risk patients, and monitoring of tre... |
|
PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis.
J. Nucl. Med. 56(1) , 127-32, (2015) Idiopathic pulmonary fibrosis is characterized by a progressive and irreversible respiratory failure. Validated noninvasive methods able to assess disease activity are essential for prognostic purpose... |
2-fluoro-2-deoxyglucose |
2-DEOXY-2-FLUOROGLUCOSE |
2-Deoxy-2-fluoro-D-glucopyranose |
2-[(18)F]fluorodeoxyglucose |
2-Deoxy-2-fluoro-D-glucose |
2-Fluoro-2-deoxy-D-glucopyranose |
2-deoxy-2-fluoro-aldehydo-D-glucose |
D-Glucose,2-deoxy-2-fluoro |
D-Glucose, 2-deoxy-2-fluoro- |
2-Fluoro-2-Deoxy-D-Glucose |
MFCD00077527 |